Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 25,119 | 27,021 | 25,646 | 18,777 | 26,504 |
| Cost of Goods | 12,838 | 15,854 | 16,426 | 14,350 | 14,267 |
| Gross Profit | 12,281 | 11,167 | 9,220 | 4,427 | 12,237 |
| Operating Expenses | 29,712 | 33,133 | 38,673 | 43,340 | 40,007 |
| Operating Income | -16,593 | -21,112 | -29,027 | -38,563 | -27,503 |
| Interest Expense | 0 | 1,190 | 1,049 | 1,062 | 1,030 |
| Other Income | 13 | 1,527 | -63 | -25,527 | -48,329 |
| Pre-tax Income | -16,580 | -20,775 | -30,139 | -65,152 | -76,862 |
| Income Tax | 263 | 70 | -713 | -1,613 | -574 |
| Net Income Continuous | -16,843 | -20,845 | -29,426 | -63,539 | -76,288 |
| Net Income | $-16,843 | $-20,845 | $-29,426 | $-63,539 | $-76,288 |
| EPS Basic Total Ops | -0.21 | -0.25 | -0.37 | -0.82 | -0.99 |
| EPS Basic Continuous Ops | -0.21 | -0.25 | -0.37 | -0.82 | -0.99 |
| EPS Diluted Total Ops | -0.21 | -0.25 | -0.37 | -0.82 | -0.99 |
| EPS Diluted Continuous Ops | -0.21 | -0.25 | -0.37 | -0.82 | -0.99 |
| EBITDA(a) | $-13,096 | $-18,795 | $-25,220 | $-34,516 | $-23,321 |